In HCC, ORAOV1 knockdown has been shown to induce apoptosis, suppress proliferation, and inhibit tumor growth in both in vitro and in vivo models, suggesting a proto-oncogenic role (Ha et al., 2021; Jiang et al., 2010). Here, LTO1 is linked to neoplasm.